[Quantification of JAK2V617F mutational burden in chronic myeloproliferative neoplasms].
Alberto
A
Alvarez-Larrán
D005260:Female; D006579:Heterozygote; D006720:Homozygote; D006801:Humans; D053614:Janus Kinase 2 / Q000235:genetics*; D008297:Male; D009196:Myeloproliferative Disorders / Q000235:genetics*; D010641:Phenotype; D017354:Point Mutation
C507924:JAK2 protein, human; D053614:Janus Kinase 2